Molecular mechanism of PPARα action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease
Michał Pawlak, Philippe Lefèbvre, Bart Staels
Journal of Hepatology, 2014
Abstract
An abstract is not available for this record. Please visit the publisher website for more details.
Related Research
- Constitutive Regulation of Cardiac Fatty Acid Metabolism through Peroxisome Proliferator-activated Receptor α Associated with Age-dependent Cardiac Toxicity 2000
- Recent Advances in Alcoholic Liver Disease II. Minireview: molecular mechanisms of alcoholic fatty liver 2004
- Cross-Talk between Peroxisome Proliferator-Activated Receptor (PPAR) α and Liver X Receptor (LXR) in Nutritional Regulation of Fatty Acid Metabolism. II. LXRs Suppress Lipid Degradation Gene Promoters through Inhibition of PPAR Signaling 2003
- Molecular mechanisms of alcoholic fatty liver: role of peroxisome proliferator-activated receptor alpha 2004
- Transcriptional Regulation of Human CYP27 Integrates Retinoid, Peroxisome Proliferator-Activated Receptor, and Liver X Receptor Signaling in Macrophages 2004
References
- PPARalpha and PPARgamma activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene. 1996
- Central Role of Pparα–Dependent Hepatic Lipid Turnover in Dietary Steatohepatitis in Mice 2003
- Peroxisome proliferator-activated receptor mediates induction of the mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase gene by fatty acids. 1994
- Peroxisome Proliferator-activated Receptor α Positively Regulates Complement C3 Expression but Inhibits Tumor Necrosis Factor α-mediated Activation of C3 Gene in Mammalian Hepatic-derived Cells 2012
- Differential regulation of the human versus the mouse apolipoprotein AV gene by PPARalpha 2009